bluebird bio (BLUE) Initiates Restructuring to Reduce Operating Expenses

Go back to bluebird bio (BLUE) Initiates Restructuring to Reduce Operating Expenses

bluebird bio Initiates Restructuring to Reduce Operating Expenses and Advance Near-term Opportunities to Bring Potentially Curative Gene Therapies to Patients in the US

April 5, 2022 7:00 AM UTC

Expected to deliver up to $160 million in cost savings over the next two years and extend the Companys cash runway through pivotal upcoming milestones in the first half of 2023

Management team to host conference call today, April 5, 2022 at 8:00 am ET

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Following a review of its strategic priorities,... More